Research output per year
Research output per year
Fingerprint
Dive into the research topics where Iain Greig is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Designer cannabinoids could be the key to pain relief without adverse effects
Greig, I. (Corresponding Author) & Ross, R. A., 3 Apr 2025, In: Nature. 640, 8057, p. 45-46 2 p.Research output: Contribution to journal › Comment/debate
Open AccessFile -
Positive allosteric modulation of the cannabinoid CB1 receptor potentiates endocannabinoid signalling and changes ERK1/2 phosphorylation kinetics
Green, H. M., Manning , J. J., Greig, I. R., Finlay, D. B., Ross, R. A. & Glass, M. (Corresponding Author), Oct 2024, In: British Journal of Pharmacology. 181, 19, p. 3642-3662 21 p.Research output: Contribution to journal › Article › peer-review
Open AccessFile2 Citations (Scopus)3 Downloads (Pure) -
Author Correction: AI is a viable alternative to high throughput screening: a 318-target study (Scientific Reports, (2024), 14, 1, (7526), 10.1038/s41598-024-54655-z)
The Atomwise AIMS Program, 16 Sept 2024, In: Scientific Reports. 14, 1, 1 p., 21579.Research output: Contribution to journal › Comment/debate › peer-review
Open Access -
Fluorinated perhexiline derivative attenuates vascular proliferation in pulmonary arterial hypertension smooth muscle cells
Griffiths, K., Grand, R. J., Horan, I., Certo, M., Wilkie, R., Mauro, C., Tseng, C.-C., Greig, I., Morrell, N. W., Zanda, M., Frenneaux, M. & Madhani, M. (Corresponding Author), Sept 2024, In: Vascular Pharmacology. 156, 9 p., 107399.Research output: Contribution to journal › Article › peer-review
Open AccessFile3 Downloads (Pure) -
Inhibitors of PTP1B/NCK1 interaction and methods of making and using same
Delibegovic, M. (Inventor), Dall'Angelo, S. (Inventor), Hamer, M. M. (Inventor), Dekeryte, R. (Inventor), McEwan, A. R. (Inventor) & Greig, I. (Inventor), 29 Aug 2024, IPC No. C07K 7/06 2006.1, A61K 38/00 2006.1 , A61K 38/08 2019.1 , A61P 3/10 2006.1 , A61P 43/00 2006.1 , C07K 7/08 2006.1, Radella Pharmaceuticals LLC, Patent No. WO/2024/178250, 22 Feb 2024, Priority date 22 Feb 2023, Priority No. 63/486,45Research output: Patent
Datasets
-
Data From AI is a viable alternative to high throughput screening: a 318-target study
AIMS Program, A. (Creator), Wallach, I. (Creator), Greig, I. (Creator) & Heifets, A. (Creator), University of Aberdeen, 2 Apr 2024
https://static-content.springer.com/esm/art%3A10.1038%2Fs41598-024-54655-z/MediaObjects/41598_2024_54655_MOESM1_ESM.zip and one more link, https://static-content.springer.com/esm/art%3A10.1038%2Fs41598-024-54655-z/MediaObjects/41598_2024_54655_MOESM2_ESM.pdf (show fewer)
Dataset
Equipment
Impacts
-
Discovery and commercialisation of new drug for rheumatoid arthritis and related conditions
Greig, I. (Coordinator), Ralston, S. (Coordinator) & van't Hof, R. J. (Coordinator)
Impact